Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
Kanika Sehgal,1 Hind J Fadel,2 Aaron J Tande,2 Darrell S Pardi,1 Sahil Khanna1 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; 2Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USACorrespondence: Sahil KhannaDivision of Gastroenterology and Hepatology, Mayo...
Main Authors: | Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/outcomes-in-patients-with-sars-cov-2-and-clostridioides-difficile-coin-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01) -
Should We Be Worried About Clostridioides difficile During the SARS-CoV2 Pandemic?
by: Eliane de Oliveira Ferreira, et al.
Published: (2020-09-01) -
Influence of Probiotics on the Development of <i>Clostridioides difficile</i> Infection in Patients Receiving Fluoroquinolones
by: Mary E. Sheffield, et al.
Published: (2021-08-01) -
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance
by: Priscilla A. Johanesen, et al.
Published: (2015-12-01) -
The microbial diversity following antibiotic treatment of Clostridioides difficile infection
by: Dana Binyamin, et al.
Published: (2021-04-01)